A Study of LY3015014 in Healthy Participants With High Cholesterol
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This is a study in healthy participants with high levels of "bad" cholesterol who are already
taking a popular type of cholesterol-lowering medication called statins. Following multiple
doses of LY3015014, investigators will study the safety and tolerability of the drug, how the
body handles the drug, and the drug's effect on the body. Participants will remain in the
study for about 3 months, not including screening. Screening is required within 28 days
before the study starts.